Regulatory Approval

A new $6.3M funding round for Dopl Technologies isn't just about money. It's about a future where telerobotics could bring critical ultrasound exams to millions.

Thermo Fisher's latest innovations tackle medicine's toughest challenges, from cancer to preeclampsia, using automation and rapid data to redefine diagnostics.

FDA clears a pivotal study for Medicus Pharma's SkinJect, a microneedle patch offering new hope for Gorlin Syndrome and a new playbook in biotech strategy.

A breakthrough trial for a rare genetic disorder unlocks $50M in funding. We explore the novel RNA science, the savvy investment, and why it's all happening in Australia.

Eutelsat nets a massive payout as the FCC reallocates critical C-band spectrum. A deep dive into the high-stakes trade-off powering America's 5G future.

A positive EMA opinion for Minoryx's NEZGLYAL offers the first-ever drug therapy for a fatal childhood disease, highlighting a key regulatory pathway.

ZAPTEST's AI automation platform gains streamlined access to military buyers, signaling a major shift in how the DoD acquires and deploys critical technology.

Upstart just won conditional approval for a national bank charter. It’s a pivotal moment that could reshape lending, but the path is lined with regulatory hurdles.

With a mixed Q1 and a promise of a stronger second half, Myriad Genetics' upcoming earnings call will be a crucial test of its strategic health and pipeline.

Dexcom's selection for the FDA's TEMPO pilot program pioneers a new path for AI-driven, preventative healthcare, shaking up the digital health market.

Spryte Medical's novel nOCT system offers microscopic views inside brain vessels. With its pivotal clinical trial enrollment complete, it's a step closer to FDA approval.

With fresh capital and key regulatory approvals, Median Technologies is launching its AI lung cancer tool, powered by a stable and record-setting iCRO business.

With FDA approval for its TorEx system, Traferox isn't just launching a device; it's reshaping the economics, logistics, and ethics of lung transplantation.

With its new IRAP PROTECTED status, Tungsten Automation gives Australian agencies a verified path to modernize sensitive workflows, balancing innovation with security.

With UK approval for its FLAMINGO-01 trial, Greenwich LifeSciences partners with a top cancer center, signaling a key move in the race to prevent breast cancer recurrence.

Science Corp.'s PRIMA device is a medical miracle, restoring sight to those with AMD. But can this BCI breakthrough navigate Europe's complex market hurdles?

IV complications cost the NHS millions. Now, an innovative monitoring system is being fast-tracked to prevent harm, save money, and improve patient care.

As a deadly Ebola outbreak grips Central Africa, OraSure's new 30-minute test offers a critical lifeline, empowering frontline workers without labs or power.

Connecticut just greenlit a statewide managed EV charging program. It’s a move that solves a critical grid problem and may reshape the future of energy in the US.

An upcoming FDA meeting on peptide compounding is more than a regulatory footnote. It's a battleground for the future of personalized and preventive care.